“Motiva® Implants represent a new standard in breast surgery, offering unparalleled safety and aesthetic outcomes,” said Dr. Calobrace.
LOUISVILLE, KY, September 28, 2024 /24-7PressRelease/ — In a groundbreaking advancement for breast augmentation, Dr. Bradley Calobrace of CaloAesthetics Plastic Surgery Center will be the first surgeon in the US, to place the newly FDA-approved Motiva® Breast Implants on Monday, September 30, 2024. This announcement comes just one day after the FDA granted approval, making it the first time in over a decade that a novel breast implant has been introduced to the U.S. market.
Motiva® Implants, which have been in the international market for nearly 15 years and has become one of, if not, the most used implant outside the U.S., are now finally available to American patients. Dr. Calobrace, a national authority and world leader in breast augmentation and mastopexy, was directly involved in the FDA clinical trials that led to their approval and will serve as the medical director of the post-approval study. He is also set to lead educational efforts across the country for the U.S. launch of Motiva® Implants.
The FDA’s approval of Motiva® is particularly notable due to its innovative design. Motiva® features a new surface technology, SmoothSilk®, which creates a biocompatible relationship between the implant and the body. This advanced design minimizes the risk of complications like capsular contracture, boasting rates of less than one percent. Furthermore, Motiva® Implants have an exceptionally low rupture rate and have reported zero cases of lymphoma, which has been a concern with other types of breast implants.
“Motiva® Implants represent a new standard in breast surgery, offering unparalleled safety and aesthetic outcomes,” said Dr. Calobrace. “As someone who has been involved in their development and approval process, I am confident that these implants will revolutionize breast augmentation for my patients and across the U.S.”
Motiva®’s TrueMonobloc® construction and advanced surface create a more natural movement and feel, offering patients a transformative solution for breast enhancement. With the Motiva® portfolio now available in the U.S., Dr. Calobrace’s patients can benefit from the most advanced implant technology on the market.
About CaloAesthetics Plastic Surgery Center
CaloAesthetics Plastic Surgery Center and CaloSpa Rejuvenation Center is the premier aesthetic practice in Louisville, KY, specializing in breast surgery, body contouring, and facial rejuvenation and non-surgical aesthetic procedures. Led by Dr. Bradley Calobrace and Dr. Juan Quintero, the practice offers personalized care with a focus on safety and patient satisfaction. For more, visit www.caloaethetics.com or www.calospa.com
# # #
